Thromboelastography Identifies Cyclic Haemostatic Variations in Healthy Women Using Oral Contraceptives

Thrombosis Research

Volumn 136, Issue 5, 2015, Pages 1022-1026

  Murray, Erin K I ^a   Murphy, Malia S Q ^a   Smith, Graeme N ^a,b   Hopman, Wilma M ^a,b   Othman, Maha ^a,c   Graham, Charles H ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c St Lawrence College   (Canada)

Author keywords

Haemostasis; Menstrual cycle; Oral contraceptives; Thromboelastography

Indexed keywords

ORAL CONTRACEPTIVE AGENT; PLACEBO; HEMOSTATIC AGENT;

ADULT; ARTICLE; BLOOD CLOTTING TEST; BLOOD SAMPLING; FEMALE; FOLLICULAR PHASE; HEMOSTASIS; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUATION; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REACTION TIME; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; YOUNG ADULT; METABOLISM; PROCEDURES;

ADULT; CONTRACEPTIVES, ORAL; HEMOSTATICS; HUMANS; MENSTRUATION; THROMBELASTOGRAPHY; YOUNG ADULT;

EID: 84948717312     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.08.011     Document Type: Article

References (16)

1. M.P. Gomes, and S.R. Deitcher Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review Arch. Intern. Med. 164 2004 1965 1976
2. H.M. Knol, R.F. Kemperman, H.C. Kluin-Nelemans, A.B. Mulder, and K. Meijer Haemostatic variables during normal menstrual cycle. A systematic review Thromb. Haemost. 107 2012 22 29
3. J.H. Essell, T.J. Martin, J. Salinas, J.M. Thompson, and V.C. Smith Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass J. Cardiothorac. Vasc. Anesth. 7 1993 410 415
4. M.S. Park, W.Z. Martini, M.A. Dubick, J. Salinas, S. Butenas, B.S. Kheirabadi, and et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time J. Trauma 67 2009 266 275 (discussion 75-6)
5. J.P. Vandenbroucke, J. Rosing, K.W. Bloemenkamp, S. Middeldorp, F.M. Helmerhorst, B.N. Bouma, and et al. Oral contraceptives and the risk of venous thrombosis N. Engl. J. Med. 344 2001 1527 1535
6. U.H. Winkler Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism Contraception 62 2000 11S 20S (discussion 37S-8S)
7. U.H. Winkler, P. Rohm, and K. Hoschen An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables Contraception 81 2010 391 400
8. C. Oral, and Study G. Hemostasis The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study Contraception 67 2003 173 185
9. In brief: FDA warning about drospirenone in oral contraceptives Med. Lett. Drugs Ther. 54 2012 33
10. S.N. Tchaikovski, M.C. Thomassen, S.D. Costa, K. Bremme, and J. Rosing Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives Thromb. Res. 134 2014 1032 1037
11. F.R. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Oral contraceptives, hormone replacement therapy and thrombosis Thromb. Haemost. 86 2001 112 123
12. S. Scarpelini, S.G. Rhind, B. Nascimento, H. Tien, P.N. Shek, H.T. Peng, and et al. Normal range values for thromboelastography in healthy adult volunteers Braz. J. Med. Biol. Res. 42 2009 1210 1217
13. W.W. Roeloffzen, H.C. Kluin-Nelemans, A.B. Mulder, N.J. Veeger, L. Bosman, and J.T. de Wolf In normal controls, both age and gender affect coagulability as measured by thrombelastography Anesth. Analg. 110 2010 987 994
14. C. Jern, K. Manhem, E. Eriksson, L. Tengborn, B. Risberg, and S. Jern Hemostatic responses to mental stress during the menstrual cycle Thromb. Haemost. 66 1991 614 618
15. E. Haus Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention Adv. Drug Deliv. Rev. 59 2007 966 984
16. D. Chen, and A. Dorling Critical roles for thrombin in acute and chronic inflammation J. Thromb. Haemost. 7 Suppl. 1 2009 122 126